Reuters logo
BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​
November 13, 2017 / 9:33 PM / 7 days ago

BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​

Nov 13 (Reuters) - Krystal Biotech Inc

* Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results

* Krystal Biotech Inc qtrly loss per share $1.26‍​

* Krystal Biotech Inc - ‍Currently preparing to file an investigational drug application for KB103 in Q1 of 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below